Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2019)

Clodi, Martin; Abrahamian, Heidemarie; Brath, Helmut; Brix, Johanna; Drexel, Heinz; Fasching, Peter; Föger, Bernhard; Francesconi, Claudia; Fröhlich‐Reiterer, Elke; Harreiter, Jürgen; Hofer, Sabine E.; Hoppichler, Friedrich; Huber, J.F.K.; Kaser, Susanne; Kautzky‐Willer, Alexandra; Lechleitner, Monika; Ludvik, Bernhard; Luger, Anton; Mader, Julia K.; Paulweber, Bernhard; Pieber, Thomas R.; Prager, Rudolf; Rami‐Merhar, Birgit; Resl, Michael; Riedl, Michaela; Roden, Michael; Saely, Christoph H.; Schelkshorn, Christian; Schernthaner, Guntram; Sourij, Harald; Stechemesser, Lars; Stingl, Harald; Toplak, Hermann; Wascher, Thomas C.; Weitgasser, Raimund; Winhofer-Stöckl, Yvonne; Zlamal-Fortunat, Sandra

doi:10.1007/s00508-019-1471-z

Cited by 10 publications

(4 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…28 For each patient, the mean of all HbA1c values was calculated and used to assign the respective patient to one of three groups: <6.5%, 6.5%–9.0%, and >9.0%. The boundaries were chosen due to different approaches to antihyperglycaemic treatment as specified in the guidelines of the Austrian Diabetes Association, 29 The use of insulin or insulin analogues was assessed as potential risk factor for DF. Thereby, a distinction was made between patients for whom this form of treatment was documented at least at one visit, and patients who have never been treated in this way.…”

Section: Subjects Materials and Methodsmentioning

confidence: 99%

Risk factors for diabetic foot complications among patients with type 2 diabetes in Austria–A registry‐based retrospective cohort study

Rossboth

Rossboth²,

Schoenherr³

et al. 2021

Endocrino Diabet & Metabol

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Subjects Materials and Methodsmentioning

confidence: 99%

Risk factors for diabetic foot complications among patients with type 2 diabetes in Austria–A registry‐based retrospective cohort study

Rossboth

Rossboth²,

Schoenherr³

et al. 2021

Endocrino Diabet & Metabol

Self Cite

View full text Add to dashboard Cite

show abstract

“…Bei Therapie mit Metformin und vorliegender Neuropathie sollten deswegen die Vitamin B12 Spiegel kontrolliert und ggf. substituiert werden [ 15 – 17 ].…”

Section: Diabetische Neuropathieunclassified

Diabetische Neuropathie und diabetischer Fuß (Update 2023)

Köhler

Eichner

Abrahamian³

et al. 2023

Wien Klin Wochenschr

Self Cite

View full text Add to dashboard Cite

ZusammenfassungDer Begriff der diabetischen Neuropathie ist eine Sammelbezeichnung für Erkrankungen des peripheren Nervensystems die als Spätkomplikation des Diabetes mellitus auftreten.Die Leitlinienempfehlungen beschreiben die klinischen Symptome und diagnostischen Möglichkeiten, sowie die Therapiemaßnahmen insbesondere bei der schmerzhaften Form der sensomotorischen Neuropathie, einschließlich der komplexen Problematik des diabetischen Fußes.

show abstract

“…One is microvascular disease, including diabetic nephropathy (DN), diabetic retinopathy (DR), diabetic encephalopathy (DE), and so forth. The other is macrovascular disease such as cardiovascular disease (CVD). , At present, the most common treatments for diabetes include metformin, exogenous insulin, sulfonylureas, and so forth . However, the side effects of these hypoglycemic drugs, such as hypoglycemia, gastrointestinal distress, and individual auditory and vestibular impairment, seriously affect patient medication adherence and even health. − While for diabetic complications, which are difficult to cure, prevention strategies are usually the best alternative options .…”

Section: Introductionmentioning

confidence: 99%

Hesperetin, a Promising Treatment Option for Diabetes and Related Complications: A Literature Review

Yang

Wang

et al. 2022

J. Agric. Food Chem.

View full text Add to dashboard Cite

The morbidity and mortality of diabetes have increased dramatically in recent decades. Novel strategies for treating diabetes and its complications with minimal side effects are in urgent need. New monomeric molecules extracted from herbal medicine, which is a form of alternative medicine, are being sought as drug candidates for the treatment of diabetes and its complications. Hesperetin (Hst), a citrus flavonoid, is of increasing interest in scientific studies recently due to its properties in combating diabetes and its complications, whereas existing studies are scattered and unsystematic. Here, we summarized the literature studies over the last 10 years to review the potential therapeutic role of Hst in the prevention and mitigation of diabetes and its complications, intending to provide promising strategies for the clinical management of diabetes and its complications.

show abstract

Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2019)

Cited by 10 publications

References 28 publications

Risk factors for diabetic foot complications among patients with type 2 diabetes in Austria–A registry‐based retrospective cohort study

Risk factors for diabetic foot complications among patients with type 2 diabetes in Austria–A registry‐based retrospective cohort study

Diabetische Neuropathie und diabetischer Fuß (Update 2023)

Hesperetin, a Promising Treatment Option for Diabetes and Related Complications: A Literature Review

Contact Info

Product

Resources

About